COVID-19: Pfizer CEO Albert Bourla tests positive, experiencing mild symptoms
Pfizer CEO Albert Bourla has started the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions.
Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. (photo credit: JOHN THYS/POOL VIA REUTERS)ByREUTERSUpdated:
